Behaviour modification and benign prostatic hyperplasia: replacement for medications.
OBJECTIVE
Lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) is a highly prevalent chronic disease. The cost impact of treatment is high. The field of behavioural treatments which could be suitable in the majority of uncomplicated patients has rarely been assessed. We summarize the recent knowledge and data from behavioural interventions chiefly the randomized controlled trial (RCT) of a self-management programme for BPH.


RESULTS
The self-management RCT has revealed that a rigorously structured behavioural programme can significantly reduce lower urinary tract symptoms severity and decrease objective symptoms like nocturia, urgency and frequency compared with standard care alone. The elements of the programme and their behavioural framework are carefully defined. The basis of the programme's effectiveness is yet unknown, but may involve changes in bladder capacity rather than simple fluid management. The sphere of behavioural interventions for BPH is lacking and requires more research.


CONCLUSIONS
Elements of the self-management programme are already being used in watchful waiting. Improving quality of life of patients with BPH through self-management will help patients and may reduce the financial burden on healthcare systems. The promotion of multidisciplinary team is a key step in implementing self-management strategies. With larger scale trials, the limitations raised and questions posed by the RCT can be further addressed.
Yap
Tet
T
Department of Urology, St. Bartholomews Hospital, Barts and London NHS Trust, West Smithfield, London, UK.
Emberton
Mark
M
D001521:Behavior Therapy; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*; D012648:Self Care